89 related articles for article (PubMed ID: 3517417)
1. [Cell differentiation induction therapy in leukemia].
Tashima M; Sawada H; Okazaki T; Mochizuki T; Ishikura H; Izumi Y; Uchino H
Nihon Rinsho; 1986 Feb; 44(2):388-94. PubMed ID: 3517417
[No Abstract] [Full Text] [Related]
2. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
[No Abstract] [Full Text] [Related]
3. [Fundamentals of leukemia differentiation therapy].
Hozumi M
Rinsho Ketsueki; 1992 May; 33(5):561-72. PubMed ID: 1630006
[No Abstract] [Full Text] [Related]
4. Potential applications of cytodifferentiation therapy in hematologic malignancies.
Breitman TR; Chen ZX; Takahashi N
Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
[TBL] [Abstract][Full Text] [Related]
5. To overcome pharmacologic and cytokinetic resistance to cytarabine in the treatment of acute myelogenous leukemia by using recombinant interleukin-3?
Brach MA; Henschler R; Mertelsmann R; Herrmann F
Semin Hematol; 1991 Jul; 28(3 Suppl 4):39-43. PubMed ID: 1780751
[No Abstract] [Full Text] [Related]
6. [Experimental model for differentiation therapy of leukemia].
Hayashi M
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1009-15. PubMed ID: 8099785
[TBL] [Abstract][Full Text] [Related]
7. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
[TBL] [Abstract][Full Text] [Related]
8. Duration of the dormant state in an established cell line of human hematopoietic cells.
Clarkson BD; Fried J; Chou TC; Strife A; Ferguson R; Sullivan S; Kitahara T; Oyama A
Cancer Res; 1977 Dec; 37(12):4506-22. PubMed ID: 336195
[No Abstract] [Full Text] [Related]
9. Role of prostaglandins in regulation of erythroleukemic cell proliferation and differentiation.
Santoro MG
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():395-9. PubMed ID: 2936130
[No Abstract] [Full Text] [Related]
10. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
[No Abstract] [Full Text] [Related]
11. [Growth inhibition and promotion of differentiation induction in cultured leukemia cell lines by deferoxamine].
Tomoyasu S; Nakamaki T; Suzuki K; Tsuruoka N
Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):568-74. PubMed ID: 3425174
[No Abstract] [Full Text] [Related]
12. [Cytosine arabinoside as a polyvalent drug in the treatment of acute non-lymphoid leukemias].
Sánchez Fayos J
Sangre (Barc); 1986; 31(5):566-73. PubMed ID: 3810411
[No Abstract] [Full Text] [Related]
13. Properties of antileukaemic drugs.
Brusamolino E
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
[No Abstract] [Full Text] [Related]
14. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
15. Acute promyelocytic leukemia: biology and treatment.
Fenaux P; Chomienne C; Degos L
Semin Oncol; 1997 Feb; 24(1):92-102. PubMed ID: 9045308
[TBL] [Abstract][Full Text] [Related]
16. Differentiation therapy for acute promyelocytic leukemia.
Fenaux P; Degos L
N Engl J Med; 1997 Oct; 337(15):1076-7. PubMed ID: 9321537
[No Abstract] [Full Text] [Related]
17. [Control of the induction of differentiation in Friend leukemia cells].
Obinata M
Nihon Rinsho; 1986 Feb; 44(2):299-304. PubMed ID: 3702066
[No Abstract] [Full Text] [Related]
18. Differentiating agents in the treatment of leukemia and myelodysplastic syndromes.
Degos L
Leuk Res; 1990; 14(8):731-3. PubMed ID: 2201824
[TBL] [Abstract][Full Text] [Related]
19. All-trans-retinoic acid in acute promyelocytic leukemia.
Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
[TBL] [Abstract][Full Text] [Related]
20. Retinoids in the treatment of acute promyelocytic leukemia. Review of the literature.
Graf N; Riesinger P; Reinhard H
Klin Padiatr; 1995; 207(2):43-7. PubMed ID: 7752598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
